摘要
Background The effects of diastolic blood pressure(DBP)on prognosis of heart failure with preserved ejection fraction(HFp EF)are still not clear,probably due to the underlying heterogeneity of HFp EF.This study was aimed to evaluate the effects of DBP in patients with atrial fibrillation(AF)-induced or AF-exacerbated HFp EF,which is a clinical syndrome with high homogeneity that has seldom been discussed.Methods In this retrospective cohort study,955 patients diagnosed with AF and HFp EF were screened.Patients with specific underlying cardiovascular diseases or other severe comorbidities were excluded.A total of 191 patients were included.Patients were assigned to one of the two groups:DBP<75 mm Hg or DBP≥75 mm Hg All-cause mortality was taken as primary endpoint,and all-cause re-hospitalization and HF specific re-hospitalization were measured as secondary endpoints.Results The mean follow-up was 49 months.Multiple established clinical risk factors and prognostic biomarkers for heart failure were adjusted.Patients with DBP<75 mm Hg demonstrated higher allcause mortality compared with patients with DBP of≥75 mm Hg[odds ratio(OR):1.669,95%confidence Interval(CI):1.040-2.679,P=0.034).The risk of all-cause re-hospitalization was also increased in the group with DBP<75 mm Hg(OR:1.426,95%CI:1.006-2.022,P=0.047).However,there was no statistically significant difference in the risk of re-hospitalization due to HF between the two groups(OR:1.005,95%CI:0.565-1.787,P=0.986).Conclusions In patients with AF-induced or AF-exacerbated HFp EF,DBP<75 mm Hg was associated with higher all-cause mortality and all-cause re-hospitalization,but was not associated with re-hospitalization due to HF.
作者
YANG Yan-hua
GUO Su-xia
LIAO Min-qi
DENG Chun-hua
CHEN Li-hua
ZHOU Guo-xiang
JIAN Zheng-wei
HE Ru-ping
HUANG Zhi-chao
YAO Yong-zhao
LU Jiong-bin
HUA Zhi-wen
HUANG Yu-li
杨燕华;郭素峡;廖敏琪;邓春花;陈丽华;周国祥;简政威;何如平;黄志超;姚永钊;卢炯斌;花智文;黄裕立(Department of Cardiology,Dongguan People's Hospital,Southern Medical University,Dongguan 523059,Guangdong,China;Department of Cardiology,Shunde Hospital,Southern Medical University(The first people's hospital of Shunde),Foshan 528300,Guangdong,China.)
基金
supported by Scientific Research Fund of Foshan,Guangdong,China (No. 2016AB003353)
the National Natural Science Foundation of China (No. 81600239)
the Science and Technology Innovation Project from Foshan,Guangdong (No. FS0AA-KJ218-1301-0006)
the Clinical Research Startup Program of Shunde Hospital,Southern Medical University (No. CRSP2019001)